Haoliang Xu
Anatomic Pathology · Chicago, ILNPI 1568858934
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AstraZeneca at 25.2% of the total. 2024 is the largest year on record at $448, more than ten times the $23 reported in 2019.
Across 45 payments — averaging $20.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$236
- Incyte Corporation$91
- Takeda Pharmaceuticals U.S.A., Inc.$85
- Seagen Inc.$76
- Daiichi Sankyo Inc.$67
- Johnson & Johnson$63
- plus $318 from 12 others
What the payments were for
- Food & beverage$937100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 12 | $236 |
| Incyte Corporation | 5 | $91 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $85 |
| Seagen Inc. | 4 | $76 |
| Daiichi Sankyo Inc. | 3 | $67 |
| Johnson & Johnson | 3 | $63 |
| Genentech USA, Inc. | 2 | $49 |
| Sanofi | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Tempus AI, Inc | 1 | $29 |
| Pfizer | 1 | $24 |
| Novartis | 1 | $24 |
| Werfen USA LLC | 1 | $20 |
| Merck | 1 | $20 |
| Sobi, Inc | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $19 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| AbbVie | 1 | $18 |
How this compares
$937 in reported general payments places this provider in the 85th percentile of 39 anatomic pathology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology in Chicago
- John HartChicago$3K
- Kammi HenriksenChicago$2K
- Jeffery GoldsteinChicago$1K
- William MullerChicago$849
- Christopher WeberChicago$626
- Jung Woo KwonChicago$598
- Ward ReevesChicago$442
- Suzanne IwazChicago$242
- Steven WhiteChicago$194
- Reina TarabeyChicago$186
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.